期刊文献+

KLF4对口腔鳞癌细胞增殖的抑制作用 被引量:9

The proliferation inhibitory effect of KLF4 in oral squamous cell carcinoma cells
下载PDF
导出
摘要 目的探讨KLF4对人口腔鳞癌细胞CAL27的增殖抑制作用。方法构建KLF4慢病毒表达载体,并转染人口腔鳞癌细胞系CAL27,转染不含KLF4开放读码框的慢病毒载体LV105作为对照。采用RT-PCR、免疫细胞化学法对KLF4表达进行鉴定。MTT实验、流式细胞术检测KLF4对口腔鳞癌细胞系CAL27的增殖抑制作用。结果 RT-PCR、免疫细胞化学实验均表明实验组细胞KLF4的表达明显高于对照组(P<0.01)。MTT实验结果表明与对照组CAL27/LV105组相比,CAL27/KLF4能够抑制细胞的增殖能力(P<0.01)。CAL27/KLF4主要通过使细胞周期中的G2/M期阻滞来抑制CAL27细胞的增殖(P<0.01)。结论 KLF4转染能够抑制口腔鳞癌细胞系CAL27的增殖能力,可能在口腔鳞状细胞癌中作为抑癌基因发挥作用。 Objective To investigate the role of KLF4 in proliferation of oral squamous cell carcinoma( OSCC)cell line CAL27. Methods OSCC cell line CAL27 was cultured in DMEM-High glucose medium with 10% FBS.Lentiviruses carrying KLF4 gene were constructed and transducted into CAL27 cells. Puromycin was used to select the stable cell line expressing KLF4 gene. RT-PCR and immunocytochemistry were used to identify the expression of KLF4.MTT and flow cytometry were performed to investigate the role of KLF4 in proliferation in stable transfection cells CAL27.Results The expression of KLF4 in CAL27 / KLF4 cells was significantly up regulated compared with CAL27 / LV105 by RT-PCR and immunocytochemistry( P 〈0. 01). Overexpression of KLF4 could inhibit the proliferation of CAL27 cells( P 〈0. 01). Moreover,The flow cytometry of cell cycle indicated that overexpression of KLF4 inhibited the proliferation of CAL27 mainly by arresting the G2 / M phase( P 〈0. 01). Conclusion CAL27 cells transduction with KLF4 could inhibit the proliferation of CAL27 cells in vitro,which may play a role as a suppressor gene in oral carcinogenesis.
出处 《北京口腔医学》 CAS 2016年第2期61-65,共5页 Beijing Journal of Stomatology
基金 国家自然科学基金(81272982) 北京市自然科学基金(7162073)
关键词 KLF4 口腔鳞状细胞癌 KLF4 Oral squamous cell carcinoma
  • 相关文献

参考文献16

  • 1宿颖,葛丽华,苗聪聪,张敏,张辛燕.三氧化二砷对口腔鳞癌细胞裸鼠移植瘤的抑制作用[J].北京口腔医学,2013,21(1):1-5. 被引量:6
  • 2Yet SF, Mca' Nulty MM, Foha SC, et al. Human EZF, a Krtippel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Bio Chem, 1998,273 (2) : 1026-1031.
  • 3Shields JM, Christy R J, Yang VW. Identification and characterization of a gene encoding a gut-enriched KrappeMike factor expressed during growth arrest. J Biol Chem, 1996,271 (33) :20009-200017.
  • 4Yoshida T, Hayashi M. Role of Krttppel-like factor 4 and its binding proteins in vascular disease. J Atheroscler Thromb ,2014,21 (5) :402- 413.
  • 5Lin CC, Sharma SB, Farrugia MK, et al. Krfippel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival. Oneogenesis ,2015,4 ( 6 ) : e155.
  • 6Tien YT, Chang MH, Chu PY, et al. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells. Vet J ,2015,205 (2) :244-253.
  • 7Wang B, Zhao M, Cui N, et al. Krtippel-like factor 4 induces apoptosis and inhibits tumorigenic progression in SK-BR-3 breast cancer cells. Febs Open Bio,2015,5 : 147-154.
  • 8Li H, Wang J, Xiao W, et al. Epigenetic alterations of Krtippel-like factor 4 and its tumor suppressor function in renal cell carcinoma. Carcinogenesis, 2013,34 ( 10 ) : 2262-2270.
  • 9Yu T, Chen X, Zhang W, et al. KLF4 regulates adult lung tumor- initiating cells and represses K-Ras-mediated lung cancer. Cell Death Differ, 2016, 23(2) :207-215.
  • 10Lin ZS, Chu HC, Yen YC, et al. Krtippel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression. Plos One, 2012,7(8) :e43593.

二级参考文献55

  • 1倪建华,陈国强,沈志祥,李秀松,刘海卫,黄燕婷,方智雯,陈赛娟,王振义,陈竺.静脉滴注三氧化二砷治疗急性早幼粒细胞白血病的药代动力学分析[J].中华血液学杂志,1997,18(5):250-253. 被引量:100
  • 2Wamakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncology, 2009,45 (4-5) :309-316.
  • 3Uarsh D, Suchak K, Moutasim KA. Stromal features are predictive of disease mortality in oral cancer patients. J Pathol, 2011 (4), 223 : 470-481.
  • 4Antman KH. Introduction: the history of arsenic trioxide in cancer therapy. Oncologist, 2001,6 ( Suppl 2 ) : 1-2.
  • 5Bomstein J, Sagi S, Haj A, et al. Arsenic trioxide inhibits the growth of human ovarian carcinoma cell line. Gynecol Onco, 2005,99 ( 3 ) : 726-729.
  • 6Cheng B, Yang X, Han Z, et al. Arsenic trioxide induced theapoptosis of laryngeal cancer via down-regulation of survivin mRNA. Auris Nasus Larynx,2008,35 ( 1 ) : 95-101.
  • 7Dilda PJ, Hogg PJ. Arsenical-based cancer drugs. Cancer Treat Rev, 2007, 33 (6) : 542-564.
  • 8Efferth T, Li PC, Konkimalla VS, et al. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med ,2007,13 (8) : 353-361.
  • 9Gazitt Y. Akay C. Arsenic trioxide: an anti cancer missile with multiple warheads. Hematology,2005, 10(3) : 205-213.
  • 10Kumar P, Benedict R, Urzua F, et al. Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis. Lab Invest ,2005, 85 (6) : 756- 767.

共引文献7

同被引文献47

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部